GenOway Sues Cellectis Over Knock-in IP

GenOway has accused Cellectis of breaching an agreement for Cellectis IP that enables it to create genetically modified animal models. The firm said that Cellectis has attempted to license the technology to GenoWay's clients directly.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.